2015 American Transplant Congress Archives

Factors Affecting Efficacy Outcomes at 12 and 24-Months After Kidney Transplantation in Patients from the A2309 Study

C. Escrig,¹ G. Colussi,² R. Roland,² M. Vergara,³ Z. Wang.³
Factors Associated With Rehospitalization and High Cost Among Health Plan Members Receiving Kidney Transplants

E. Lee,¹ Y. Zhou,² B. Suehs,² B. Franks,¹ B. Kassman,¹ J. Spalding,¹ G. Thal.¹
Factors Influencing Cost Among Kidney, Liver, and Heart Transplant Patients in a Private Payer Setting

W. Bannister,¹ C. Wu,¹ M. Schnitzler,² F. Irwin,¹ A. Bonagura.¹
Failure to Account for Critical Candidate Characteristics Significantly Biases Kidney Transplant Center Report Cards Measuring Time to Transplant

L. Kayler,¹ J. Schold.²
Fast Track of Adult-to-Adult Live Donor Liver Transplant Recipients: Avoiding ICU Admission Reduces Complications and Post Transplant Hospital Stay

J. Echeverri, N. Goldaracena, A. Singh, G. Sapisochin, N. Selzner, M. Cattral, P. Greig, L. Lilly, I. McGilvray, G. Levy, A. Ghanekar, E. Renner, D. Grant, S. McCluskey, M. Selzner.
Favorable Long-Term Outcome of Late-Onset CMV Disease in D+R- Kidney Transplant Recipients Treated With Universal Prophylaxis

H. Kaminski,¹ L. Couzi,^1,2 I. Garrigue,^3,4 J. Déchanet-Merville,² P. Merville.^1,2
Favorable Results of ABO Incompatible Renal Transplantation Without B Cell Targeted Therapy: Advantages and Disadvantages of Rituximab Pretreatment

M. Okada,¹ K. Futamura,¹ K. Itou,¹ T. Yamamoto,¹ T. Hiramitsu,¹ M. Tsujita,¹ N. Goto,¹ S. Narumi,¹ Y. Watarai,¹ A. Katayama,² K. Uchida,³ T. Kobayashi.⁴
Feasibility of Regulatory T Cell Cryopreservation and Banking for Clinical Therapeutic Applications

K. Gołąb,¹ O. Savari,¹ S. Ramachandran,¹ Z. Tekin,¹ M. Tibudan,¹ J. Millis,¹ P. Trzonkowski,² P. Witkowski.¹
Fibrosis, Not Quantitative NGAL-Staining, in Day-10 Protocol Biopsies Predicts Prolonged Duration of Functional Delayed Graft Function in a Cohort of DCD Kidney Transplant Recipients

J. Bank,¹ M. Reinders,¹ M. Mallat,¹ N. Schlagwein,¹ S. van der Kooij,¹ D. van Gijlswijk,¹ I. Bajema,² C. van Kooten,¹ H. de Fijter.¹
Final Results from the BENEFIT-EXT Trial: A 7 Year Follow-Up of Belatacept Treated Patients

S. Florman,¹ J. Medina Pestana,² M. Rial,³ L. Rostaing,⁴ D. Kuypers,⁵ F. Mühlbacher,⁶ M. Polinsky,⁷ U. Meier-Kriesche,⁷ J. Grinyó,⁸ A. Durrbach.⁹
Financial Burden of Laparoscopic Living Kidney Donation

J. Wiseman, D. Larson, D. Berglund, C. Jacobs, C. Garvey, H. Ibrahim, A. Matas.
Financial Impact of an Advanced Liver Disease Service on a Tertiary Health System

A. Masoumi,¹ S. Hanish,² J. LaMattina,² C. Njoka,¹ W. Hutson,² D. Potosky,² R. Barth.²
First Clinical Data With an Improved C1q-Luminex® Assay

A. Roodenburg,² J. Bamoulid,¹ O. Staeck,¹ C. Schoenemann,² N. Lachmann,² K. Budde.¹
First Dose Tacrolimus Level Is Better Than CYP3A5 Genotyping in Prediction of Target Tacrolimus Dose

N. Townamchai,¹ W. Chancharoenthana,¹ S. Wattanatorn,¹ S. Vadcharavivad,² P. Chariyavilaskul,³ A. Leelahavanichkul,⁴ Y. Avihingsanon,¹ K. Praditpornsilpa.¹
Focal Segmental Glomerulosclerosis Recurrence in Renal Transplant Recipients Treated With Belatacept

W. Kitchens,¹ A. Farris,² S. Pastan,¹ T. Pearson,¹ C. Larsen,¹ A. Adams.¹
Forty-Seven Consecutive Simultaneous Liver-Kidney Transplants With Steroid Free Immunosuppression After Rabbit Antithymocyte Globulin Induction

D. Hall, V. Puri, S. Mabry, J. Vanatta, J. Eason.
Fracture Incidence in Adult Kidney Transplant Recipients

K. Naylor,^1,2 S. Jamal,³ G. Zou,¹ E. McArthur,⁴ N. Lam,^1,2 W. Leslie,⁵ A. Hodsman,² J. Kim,^4,6 G. Knoll,⁷ L.-A. Fraser,¹ J. Adachi,⁸ A. Garg.^1,2,4
Frailty and Length of Stay in KT Recipients

M. McAdams DeMarco, E. King, X. Luo, L. Kucirka, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Frailty in Patients Being Evaluated for Kidney Transplantation

M. McAdams DeMarco, I. Olorundare, N. Desai, N. Dagher, B. Lonze, R. Montgomery, D. Segev.
Frequencies of CD4⁺25^hiFoxp3⁺T Cells in Long-Term Follow-Up of Sirolimus-Converted Kidney Transplant Recipients

O. Traitanon,^1,2 A. Alvarado,¹ E. Tantisattamo,^1,2 A. Shetty,^1,2 M. Ansari,^1,2 J. Mathew,¹ J. Leventhal,¹ V. Mas,³ L. Gallon.^1,2
Functional Decline in Liver Transplant Candidates: Results from the Functional Assessment in Liver Transplantation (FrAILT) Study

J. Lai, K. Covinsky, J. Dodge, S. Sen, S. Feng.
Functional Status Predicts Mortality After Liver Transplant

N. Dolgin,^1,2 P. Martins,¹ F. Anderson,^1,2 A. Bozorgzadeh.¹
Furthering the Link Between Ischemia and Immunity: Development of New Antibody Following Prolonged Delayed Graft Function

A. Gilbert,¹ E. Hall,¹ O. Timofeeva,² M. Awwad,² M. Grafals,¹ P. Weems,¹ D. Li,² S. Rosen-Bronson,² J. Moore,¹ B. Javaid,¹ M. Cooper.¹